Emerging Complications: Diabetic Retinopathy - PowerPoint PPT Presentation

1 / 21
About This Presentation
Title:

Emerging Complications: Diabetic Retinopathy

Description:

Emerging Complications: Diabetic Retinopathy Irl B. Hirsch, M.D. University of Washington Natural History 657 type 1 patients diagnosed between 1950 and 1980 with ... – PowerPoint PPT presentation

Number of Views:250
Avg rating:3.0/5.0
Slides: 22
Provided by: Irl1
Category:

less

Transcript and Presenter's Notes

Title: Emerging Complications: Diabetic Retinopathy


1
Emerging ComplicationsDiabetic Retinopathy
  • Irl B. Hirsch, M.D.
  • University of Washington

2
Natural History
Pittsburgh Epidemiology of Diabetes
Complications Study
  • 657 type 1 patients diagnosed between 1950 and
    1980 with mean duration of 20 years
  • NPDR universal after 20 years duration
  • PDR present in 70 after 30 years duration
  • With shorter durations, PDR more prevalent in
    females

Orchard TJ et al Diabetes 1990391116-24
3
Natural History
Pittsburgh Epidemiology of Diabetes
Complications Study
  • The prevalence of retinopathy and overt
    nephropathy in 552 White T1 subjects mean DM
    duration 20.8 yr was significantly greater in
    subjects diagnosed during puberty compared with
    those diagnosed before puberty.

Kolstraba JN et al Diabetes Care. 198912686-9
4
Natural History
Pittsburgh Epidemiology of Diabetes
Complications Study
  • Results concerning the risk of diabetes-related
    mortality in a cohort of 1582 subjects (mean
    duration 12.9 yr) indicated that postpubertal
    duration of T1DM may be a more accurate
    determinant of the development of microvascular
    complications and diabetes-related mortality than
    total duration, and it is suggested that the
    contribution of the prepubertal years of diabetes
    to long-term prognosis may be minimal.

Kolstraba JN et al Diabetes Care. 198912686-9
5
Major Question RE PDR and T1DM
When does the clock start ticking?
Does pre-pubertal status protect against DR? How
does puberty impact duration of diabetes for
teens and young adults?
6
German Registry Study
University of Ulm
  • N441, median age 15.5 years, median duration
    DM 6.3 years
  • 19 BID NPH/REG 42 TID injections, 40 QID
    injections
  • Shortest duration prior to Dx of NPDR was 2.2
    years
  • Youngest child with NPDR 5.5 years old

Holl RW, et al J Pediatr 199813279--794
7
German Registry Study
  • Life table analysis revealed a median duration of
    16.6 years until the occurrence of early DR

Holl RW, et al J Pediatr 199813279--794
8
German Registry Study
Pubertal Duration
  • Comparing children with onset before to
    during/after puberty, those with pre-pubertal Dx
    developed DR a median of 10.9 years after puberty
    compared to 15.1 years with pubertal onset of DM

Holl RW, et al J Pediatr 199813279--794
9
German Registry Study
  • Good glycemic control (A1C lt 7.5) delayed the
    onset of DR by about 3 years

NOTE DR was generally not prevented by good
control
Holl RW, et al J Pediatr 199813279--794
10
German Registry Study
  • Pre-pubertal glycemic exposure does not protect
    against DR
  • Metabolic control should be attempted
    irrespective of age

Holl RW, et al J Pediatr 199813279--794
11
Ophthalmology 19931001125-31
12
Missouri DR Data
  • N420 with onset lt 20 years of age enrolled
    between 1979 and 1988
  • Annual stereo fundus photographs
  • Results
  • No DR before 2 years in anyone
  • 50 by 9 years DM duration
  • 100 by 20 years duration
  • DR developed 2 years sooner in females, but no
    difference when considering pubertal status

13
(No Transcript)
14
Missouri PDR Data
  • PDR developed in 11 patients
  • Higher A1C with PDR (10.9 vs. 8.6)
  • The higher the A1C, the sooner PDR detected

15
Missouri DR Data Conclusions
  • Long-term glycemic control impacts both the
    appearance and the progression of DR
  • Prepubertal duration of diabetes is a significant
    risk factor for the development of DR

16
What About Screening of DR in Youth
  • 667 children and adolescents at the Childrens
    Hospital at Westmead, Sydney Australia
  • DR in lt 11 years old
  • 16 baseline 1-2 years later, regressed in 80,
    progressed in none
  • DR in gt 11 year olds
  • 22 baseline 1-2 years later, regressed in 36,
    progressed in 13

17
Screening of DR in Diabetic Youth
Risk of DR progression in children lt 11 years of
age
Maguire A et al. Diabetes Care 200528 509-13
18
Screening of DR in Diabetic Youth
Risk of DR progression in children gt 11 years of
age
Maguire A et al. Diabetes Care 200528 509-13
19
Screening of DR in Diabetic Youth
  • In the highest risk group (gt 10 years duration DM
    with A1C at any screening gt 10) DR progressed
    significantly after 2 years but not until after 3
    years in the group whose A1C was always lt 10
  • Although patients with diabetes gt 10 years were lt
    likely to have an improvement of their DR after 1
    year, there was no increase in DR at 1 year
    follow-up

Maguire A et al. Diabetes Care 200528 509-13
20
Screening of DR in Diabetic Youth
  • These studies suggest that adolescents in
    reasonable metabolic control could safely be
    screened every 2 years instead of the current
    yearly recommendation
  • In younger children the next screening could be gt
    2 years later
  • Those with poor control (A1C gt 10), duration gt
    10 years, or significant DR should be screened
    more frequently

Maguire A et al. Diabetes Care 200528 509-13
21
Current ADA Recommendations
  • 1. Adults and children aged 10 years or older
    with type 1 diabetes should have an initial
    dilated and comprehensive eye examination by an
    ophthalmologist or optometrist within 5 years
    after the onset of diabetes. (B)
  • 2. Subsequent examinations for type 1 and type 2
    diabetic patients should be repeated annually by
    an ophthalmologist or optometrist. Less frequent
    exams (every 23 years) may be considered
    following one or more normal eye exams.
    Examinations will be required more frequently if
    retinopathy is progressing. (B)

Diabetes Care 33 (Suppl 1) S11-61, 2010
Write a Comment
User Comments (0)
About PowerShow.com